Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2018

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Who we help

As the trusted partner to the top 50 global pharmaceutical companies and top 10 contract research organizations, our pharmaceutical data, insights, and analytics are used by businesses operating in all areas of the industry.

Our Specialties

For pharmaceutical companies

Bring game-changing drugs to market more efficiently using our insight and analysis. We’ll help you beat the competition and improve healthcare and patient outcomes.

For contract research organizations

We can help position your organization to win more business and enhance your drug development services. You’ll make better-informed, data-driven decisions while bidding on and implementing clinical trials.

For consultancies

Focus on your clients and expand your business opportunities with Pharma Intelligence. We’ll help you build a complete picture of the fast-changing pharmaceutical market with our insight and expertise.

For marketing agencies

You need to understand and communicate complex information simply and persuasively, often across a variety of channels. We can help with branding, multi-channel communication and more.

For the medtech sector

Your trusted source for industry data, analysis, opinion and news. Access the information you need to inform deal making and business cases for product development and quality control and compliance.

Relevant products

Trialtrove: gold standard clinical trials intelligence

Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.

Key benefits:

Curated by experts
Clinical trial landscape view
Standard of care insights

Datamonitor Healthcare: data analysis and insight

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

Key benefits:

Prioritize market opportunities
Identify unmet needs
Make informed decisions

Scrip: industry news and insights

Key benefits:

Follow market developments
Go beyond the news
Hear from news makers

Awareness

Global Generics Podcast 2018

20 Jun 2018

Listen to this podcast with Generics bulletin editor Aidan Fry and deputy editor David Wallace. The Global Generics & Biosimilars Awards reward ‘best practice’ in the two industries, while at the same time encouraging improvements in every aspect of the way business is conducted.

Full podcast
Biomedtracker

Regenerative Medicine Advanced Therapy Webinar

By Amanda Micklus 19 Jun 2018

Gain a deeper understanding of the implications of the Regenerative Medicine Advanced Therapies (RMAT) designation and the significance of its support and advancement by the FDA in this webinar recording, "RMAT Designation – Impact on Regenerative Medicine Sector".

Topic Drug development landscape

Full video
Awareness

Acute Myeloid Leukemia Market Outlook Seminar

By Dominique Fontanilla 19 Jun 2018

There has been little change to standard treatment for AML in recent years; however, 2017 saw a flurry of new targeted drug approvals, sparking significant market growth. Patient age remains the biggest factor in driving treatment decisions for AML. Cases of AML are expected to increase, and prognosis remains poor – especially among older adults. Drug developers are targeting patient segments with high unmet clinical need to gain access to the AML market and the budget impact of AML is expected to grow considerably.

Topic Cancer

Full video
Awareness

Trends in Gene Therapy Seminar

By Patricia Reilly 19 Jun 2018

The promises of gene therapy are taking a long time to be fulfilled, in part due to challenges in developing gene vectors capable of safe and efficient delivery of therapeutic genes (transgenes) into patients’ cells. Nonetheless, these challenges are being addressed in innovative ways. A variety of first-generation vectors, both viral and non-viral, have been employed in clinical trials with varying degrees of success, and the experience gained is guiding the design of next-generation vectors.

Full video
Meddevicetracker

Robotic Surgery 4.0 Innovative Robotic Assisted Systems & their Applications

By Tina Tan 15 Jun 2018

The webinar will provide a thought leadership perspective on the key challenges and trends in the emerging Robotic Surgery market.

Topic Digital Health Research

Full webinar
Medtech Insight

Procept BioRobotics Believes Aquablation Could Dominate BPH Treatment... If It Gets Coverage

By Reed Miller 14 Jun 2018

Results of the WATER II trial confirm that Aquablation is a safe and effective treatment of benign prostate hyperplasia for large prostates, and manufacturer Procept BioRobotics is confident the procedure will eventually displace all other prostate resection techniques because it is easy for surgeons to learn.

Topic Company analysis Business strategies

View article
In Vivo

World In Motion The Shape Of The New Health Care Technology Ecosystem In 2022

By Ashley Yeo 14 Jun 2018

The health products industry, methods of care delivery and even the public's expectations for improved tools to prevent, monitor and treat disease have transformed dramatically in the past five years. The changes anticipated over a similar period ahead are potentially even more marked, with business continuity impacts for medtech and pharma concerns, according to Deloitte LLP experts who were on the circuit at health care industry events in Germany and the UK this spring.

Topic Business strategies Digital Health

View article
In Vivo

How The EHR And New Data Streams Are Influencing Clinical Practice

By Mark Ratner 14 Jun 2018

A plethora of clinical studies are showing that new types of data, often captured in the EHR, can help improve the correlation between treatments and outcomes and favorably affect patient care as well as enhance drug development.

View article
Pink Sheet

US FDA's Plan On Right To Try: Big On Congressional Engagement, Short On Policy Details

By Sue Sutter 14 Jun 2018

Internal group headed by Principal Deputy Commissioner Rachel Sherman will develop implementation recommendations, which could include new guidance, regulations, a Q&A document or ‘nothing at all,’ Commissioner Gottlieb tells BIO annual meeting; he promises consultation with the law’s supporters and critics on Capitol Hill ‘to fully understand what the intent was with different provisions.’

Topic FDA

View article
Pink Sheet

FDA Finally Approves Avastin In First-Line Ovarian Cancer

By Emily Hayes 14 Jun 2018

Genentech says it worked closely with the agency to bring the drug to women with earlier-stage disease.

Topic Cancer FDA

View article
Medtech Insight

New Reasons Not To Use EU MDR's Four-Year Extension, But Comply Earlier Or Retire Products Instead

By Amanda Maxwell 14 Jun 2018

The new EU Medical Device Regulation offers companies an option to market CE-marked devices for an extra four years under current directives. But more hurdles are being identified that make this option less attractive.

Topic Brexit Business strategies

View article
Scrip

Aim High And Keep Pushing China Biotech Dealmakers Borrow Page From Trump

By Brian Yang 14 Jun 2018

Recent biotech investment deals involving WuXi, Oncologie and Siranomics show Chinese investors are becoming increasingly bold and savvy in betting on innovative assets both inside and outside the country.

Topic BioPharmaceutical

View article
Scrip

Levin Calls Takeda Shire Merger Inspired Says Entire Value Chain Must Address Pricing Issue

By Joseph Haas 14 Jun 2018

Having previously criticized the biopharma industry for squandering the benefits of US tax reform, the former Teva CEO called for more M&A deals that offer a clear strategic rationale, pointing to Takeda/Shire as an example.

Topic BioPharmaceutical

View article
Datamonitor Healthcare

Datamonitor Healthcare Analyst Podcast: Post-ASCO Podcast 1

By Jack Allen 08 Jun 2018

Zach McLellan and Jack Allen are joined by guest analysts Dominique Fontanilla and Hardik Patel. The group discusses key recent events that occurred at the American Society of Clinical Oncology 2018 Annual Meeting.

Topic Cancer

Full podcast
Datamonitor Healthcare

Datamonitor Healthcare Analyst Podcast: Post-ASCO Podcast 2

By Jack Allen 08 Jun 2018

Zach McLellan and Jack Allen are joined by guest analyst Maria Berezina. The group discusses key recent events that occurred at the American Society of Clinical Oncology 2018 Annual Meeting.

Topic Cancer

Full podcast

Latest headlines

In Vivo

20 Jun 2018

Pharma’s New R&D Models: Federating Innovation

Link
Medtech Insight

20 Jun 2018

Roche Pushes Personalization With $2.4bn Foundation Buy-Out

Link
Pink Sheet

20 Jun 2018

Faster Submissions For Orphan Designation Possible As EMA’s Online Portal Goes Live

Link
Medtech Insight

19 Jun 2018

Warning Letter Roundup & Recap – June 19, 2018

Link
Medtech Insight

19 Jun 2018

Patent Office Judge Suing Medtronic For Wrongful Termination

Link
Medtech Insight

19 Jun 2018

Size Doesn't Matter: US FDA Refines Dig-Health Pre-Cert Model

Link
Medtech Insight

19 Jun 2018

Physician Suit Alleges Stryker Sold Uncleared Surgical Tool

Link
Pink Sheet

19 Jun 2018

340B Legislative Reforms: Where Do We Go From Here?

Link
Scrip

19 Jun 2018

Sarepta Outlines A Fast Path Forward For Its DMD Gene Therapy

Link
Pink Sheet

19 Jun 2018

Eagle Will Be Last Firm To Bypass FDA's Orphan Drug Exclusivity Requirement

Link
Scrip

19 Jun 2018

Deal Watch, Focus On Asia: Cipla Licenses India Rights To Lilly’s Basalgar

Link
Pink Sheet

19 Jun 2018

US FDA’s Patient Input Guidance Opens Door Wider To Social Media Data Collection

Link
Scrip

19 Jun 2018

Catalyst Biosciences Drops On Study Halt

Link
Scrip

19 Jun 2018

£88m Series B For Syncona-backed Freeline To Advance Liver Gene Therapy Focus

Link
Pink Sheet

19 Jun 2018

Increase In Antibacterial R&D Prompts EMA Proposal For Improved Guidance

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Who we help

Our Specialties

For pharmaceutical companies

For contract research organizations

For consultancies

For marketing agencies

For the medtech sector

Relevant products

Below are the Product Brand List

Trialtrove: gold standard clinical trials intelligence

Datamonitor Healthcare: data analysis and insight

Scrip: industry news and insights

Pharma Intelligence latest insights

Latest headlines

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store